(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged havde 526 af de 793 deltagende patienter "stort behov", da anden systemisk behandling ikke virkede eller ikke kunne anvendes.
Raptiva has been studied in five main studies involving over 3,000 patients with moderate to severe plaque psoriasis.